09/16/2025 4:30 PM | Lexeo Therapeutics (Issuer) Townsend Richard Nolan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/10/2025 3:59 PM | Lexeo Therapeutics (Issuer) Townsend Richard Nolan (Reporting)
| Form 4/A | |
09/03/2025 1:00 PM | Lexeo Therapeutics (Issuer) Tamayo Louis Edward (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/27/2025 5:51 PM | Lexeo Therapeutics (Issuer) Tamayo Louis Edward (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/20/2025 3:58 PM | Lexeo Therapeutics (Issuer) See Tai Sandi (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/20/2025 4:00 PM | Lexeo Therapeutics (Issuer) Townsend Richard Nolan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/20/2025 4:02 PM | Adler Eric (Reporting) Lexeo Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/20/2025 4:03 PM | Lexeo Therapeutics (Issuer) Robertson Jenny (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/20/2025 4:05 PM | Lexeo Therapeutics (Issuer) Otero Jose Manuel (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/18/2025 2:18 PM | Lexeo Therapeutics (Subject) Robertson Jenny (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/18/2025 2:20 PM | Lexeo Therapeutics (Subject) See Tai Sandi (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
08/18/2025 2:24 PM | Lexeo Therapeutics (Subject) Townsend Richard Nolan (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/18/2025 2:26 PM | Adler Eric (Reporting) Lexeo Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/18/2025 2:31 PM | Lexeo Therapeutics (Subject) Otero Jose Manuel (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2025 10:46 AM | JANUS HENDERSON GROUP PLC (Filed by) Lexeo Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
08/14/2025 6:31 AM | Lexeo Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/14/2025 6:33 AM | Lexeo Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/14/2025 5:40 AM | BALYASNY ASSET MANAGEMENT L.P. (Filed by) Lexeo Therapeutics (Subject)
| Form SCHEDULE 13G | |
07/01/2025 7:09 AM | Lexeo Therapeutics (Filer)
| Form 424B3 | |
06/30/2025 11:15 PM | Lexeo Therapeutics (Filer)
| Form EFFECT | |
06/30/2025 3:47 PM | Lexeo Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/26/2025 3:56 PM | Lexeo Therapeutics (Filer)
| Form S-3/A | |
06/05/2025 3:52 PM | Lexeo Therapeutics (Filer)
| Form DEFA14A | |
06/04/2025 3:51 PM | Frazier Life Sciences Public Fund, L.P. (Filed by) Lexeo Therapeutics (Subject)
| Form SCHEDULE 13G | |
06/04/2025 3:04 PM | Affinity Asset Advisors, LLC (Filed by) Lexeo Therapeutics (Subject)
| Form SCHEDULE 13G | |
05/27/2025 6:32 AM | Lexeo Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/16/2025 2:35 PM | Adler Eric (Reporting) Lexeo Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2025 2:36 PM | Lexeo Therapeutics (Subject) See Tai Sandi (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2025 2:41 PM | Lexeo Therapeutics (Subject) Robertson Jenny (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2025 2:51 PM | Lexeo Therapeutics (Subject) Townsend Richard Nolan (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2025 8:58 AM | D1 Capital Partners L.P. (Filed by) Lexeo Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
05/14/2025 11:00 AM | JANUS HENDERSON GROUP PLC (Filed by) Lexeo Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
05/13/2025 5:55 AM | Lexeo Therapeutics (Subject) MIZUHO FINANCIAL GROUP INC (Filed by)
| Form SCHEDULE 13G/A | |
05/12/2025 8:00 AM | Adage Capital Management, L.P. (Filed by) Lexeo Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
05/12/2025 6:02 AM | Lexeo Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/12/2025 6:03 AM | Lexeo Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/09/2025 4:44 PM | Lexeo Therapeutics (Issuer) See Tai Sandi (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/09/2025 4:46 PM | Lexeo Therapeutics (Issuer) Robertson Jenny (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/09/2025 4:48 PM | Lexeo Therapeutics (Issuer) Otero Jose Manuel (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/07/2025 5:06 AM | Lexeo Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/01/2025 6:58 PM | Lexeo Therapeutics (Issuer) Townsend Richard Nolan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
03/24/2025 3:17 PM | Lexeo Therapeutics (Filer)
| Form S-8 POS | |
03/24/2025 6:52 AM | Lexeo Therapeutics (Filer)
| Form 424B5 | |
03/24/2025 6:01 AM | Lexeo Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/24/2025 6:03 AM | Lexeo Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/24/2025 6:04 AM | Lexeo Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/21/2025 4:08 PM | Lexeo Therapeutics (Issuer) Robertson Jenny (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2025 4:09 PM | Adler Eric (Reporting) Lexeo Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2025 4:09 PM | Lexeo Therapeutics (Issuer) See Tai Sandi (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2025 4:10 PM | Lexeo Therapeutics (Issuer) Townsend Richard Nolan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/19/2025 3:06 PM | Adler Eric (Reporting) Lexeo Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2025 11:03 AM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by) Lexeo Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025 10:55 AM | JANUS HENDERSON GROUP PLC (Filed by) Lexeo Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025 8:00 AM | Lexeo Therapeutics (Subject) Omega Fund VI, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
02/13/2025 9:24 AM | Lexeo Therapeutics (Subject) MIZUHO FINANCIAL GROUP INC (Filed by)
| Form SCHEDULE 13G | |
02/12/2025 8:35 AM | Adage Capital Management, L.P. (Filed by) Lexeo Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/22/2025 3:55 PM | Lexeo Therapeutics (Issuer) Rasbach Kyle (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/13/2025 6:35 AM | Lexeo Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/10/2025 3:55 PM | Adler Eric (Reporting) Lexeo Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2025 3:55 PM | Lexeo Therapeutics (Issuer) See Tai Sandi (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2025 3:55 PM | Lexeo Therapeutics (Issuer) Robertson Jenny (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2025 3:55 PM | Lexeo Therapeutics (Issuer) Otero Jose Manuel (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2025 3:55 PM | Lexeo Therapeutics (Issuer) Townsend Richard Nolan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/27/2024 1:59 PM | Lexeo Therapeutics (Issuer) Rasbach Kyle (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
12/19/2024 11:15 PM | Lexeo Therapeutics (Filer)
| Form EFFECT | |
12/19/2024 6:01 AM | Lexeo Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/13/2024 7:19 AM | Lexeo Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
12/12/2024 4:00 PM | Lexeo Therapeutics (Issuer) Townsend Richard Nolan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/10/2024 4:18 PM | Lexeo Therapeutics (Subject) Townsend Richard Nolan (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/03/2024 11:15 PM | Lexeo Therapeutics (Filer)
| Form EFFECT | |
11/26/2024 4:00 PM | CHOLMONDELEY PAULA H (Reporting) Lexeo Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/14/2024 4:49 PM | Lexeo Therapeutics (Subject) Lundbeckfond Invest A/S (Filed by)
| Form SC 13G/A | |
11/14/2024 11:32 AM | JANUS HENDERSON GROUP PLC (Filed by) Lexeo Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024 11:23 AM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by) Lexeo Therapeutics (Subject)
| Form SC 13G/A | |
11/13/2024 4:31 PM | Lexeo Therapeutics (Issuer) Tanguler Tolga (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
11/13/2024 4:33 PM | Lexeo Therapeutics (Issuer) Townsend Richard Nolan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/13/2024 4:34 PM | Lexeo Therapeutics (Issuer) Tanguler Tolga (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/13/2024 6:31 AM | Lexeo Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/13/2024 6:32 AM | Lexeo Therapeutics (Filer)
| Form 424B3 | |
11/13/2024 6:33 AM | Lexeo Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/13/2024 6:35 AM | Lexeo Therapeutics (Filer)
| Form 424B3 | |
11/12/2024 8:31 AM | Adage Capital Management, L.P. (Filed by) Lexeo Therapeutics (Subject)
| Form SC 13G | |
10/30/2024 5:15 AM | Lexeo Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/30/2024 5:17 AM | Lexeo Therapeutics (Filer)
| Form 424B3 | |
10/15/2024 12:45 PM | Lexeo Therapeutics (Issuer) Townsend Richard Nolan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/09/2024 3:30 PM | Lexeo Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/09/2024 3:32 PM | Lexeo Therapeutics (Filer)
| Form 424B3 | |